Carl Zeiss Meditec AG

DB:AFX Stock Report

Market Cap: €5.2b

Carl Zeiss Meditec Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Markus Weber

Chief executive officer

€1.1m

Total compensation

CEO salary percentage40.5%
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure4.6yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Markus Weber's remuneration changed compared to Carl Zeiss Meditec's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€203m

Mar 31 2024n/an/a

€261m

Dec 31 2023n/an/a

€277m

Sep 30 2023€1m€426k

€290m

Jun 30 2023n/an/a

€308m

Mar 31 2023n/an/a

€278m

Dec 31 2022n/an/a

€307m

Sep 30 2022€1m€298k

€294m

Compensation vs Market: Markus's total compensation ($USD1.11M) is below average for companies of similar size in the German market ($USD3.50M).

Compensation vs Earnings: Markus's compensation has been consistent with company performance over the past year.

CEO

Markus Weber

2.8yrs

Tenure

€1,050,400

Compensation

Dr. Markus Weber is CEO & Chairman of Management Board of Carl Zeiss Meditec AG from January 01, 2022 and served as its President since January 01, 2022 until December 2022. He joined ZEISS Semiconductor M...

Leadership Team

NamePositionTenureCompensationOwnership
Markus Weber
CEO & Chairman of Management Board2.8yrs€1.05mno data
Justus Wehmer
CFO & Member of the Management Board6.1yrs€799.30kno data
Christian Munster
Head of Global Regulatory & Clinical Affairs1.8yrsno datano data
Stefanie Spanagel
Chief Operating Officerno datano datano data
Sebastian Frericks
Director of Investor Relationsno datano datano data
Eva-Maria Heine
Chief Human Resources Officerno datano datano data
Steven Schallhorn
Chief Medical Officer for Global Ophthalmic Devices8.1yrsno datano data
Andrew Chang
Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec4.7yrsno datano data
Euan Thomson
President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit4.5yrsno datano data
Magnus Reibenspiess
Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technologyno datano datano data

4.6yrs

Average Tenure

59yo

Average Age

Experienced Management: AFX's management team is considered experienced (4.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christian Munster
Head of Global Regulatory & Clinical Affairs1.7yrsno datano data
Karl Lamprecht
Chairman of the Supervisory Board4.4yrsno datano data
Michael Kaschke
Honorary Chairman of the Supervisory Board3.5yrs€43.10kno data
Isabel De Paoli
Member of the Supervisory Board4.4yrs€36.00kno data
Peter Kameritsch
Member of the Supervisory Board3.5yrs€55.00kno data
Heike Madan
Employee Representative Member of the Supervisory Board1.7yrsno datano data
Tania von der Goltz
Member of the Supervisory Board6.6yrs€52.00kno data
Rene Denner
Employee Representative Deputy Chairman of Supervisory Board5.1yrs€40.50kno data
Jeffrey Marx
Employee Representative Member of Supervisory Board4.7yrs€36.00kno data
Torsten Reitze
Member of Supervisory Board3.5yrsno datano data
Brigitte Koblizek
Employee Representative Member of the Supervisory Board2.7yrs€19.20kno data
Falk Bindheim
Employee Representative Member of the Supervisory Board1.7yrsno datano data

3.5yrs

Average Tenure

53yo

Average Age

Experienced Board: AFX's board of directors are considered experienced (3.5 years average tenure).